dsm-firmenich has announced that it has completed its share repurchase programme for a value of €1.08bn, ahead of the expected completion at the end of January 2026.
On February 13th, 2025, dsm-firmenich announced its intention to repurchase ordinary shares with an aggregate market value of €1bn and reduce its issued capital.
dsm-firmenich later announced plans to repurchase another €80m worth of ordinary shares to cover commitments under the Group’s share-based compensation plans.
In accordance with regulations, dsm-firmenich informs the market that during the period from November 24th, 2025, up to and including December 1st, 2025, a total number of 450,950 shares have been repurchased on its behalf.
The shares were repurchased at an average price of €70.96 per share for a total amount of €32m.
This repurchase concludes the share buyback programme, with a total number of shares repurchased under this programme of 12,930,796 shares at an average price of €83.52 and for a total consideration of €1.08bn.
Of the total, 881,355 shares have been repurchased to cover commitments under the Group’s share-based compensation plans and 12,049,441 shares have been repurchased for capital reduction purposes.
dsm-firmenich intends to cancel 12,049,441 shares in the first quarter of 2026.
This cancellation will reduce the number of issued shares by around four-and-a-half per cent from 265,676,388 shares to 253,626,947 shares.